Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus
- 1 July 1997
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 182 (3), 299-306
- https://doi.org/10.1002/(sici)1096-9896(199707)182:3<299::aid-path856>3.0.co;2-8
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Hodgkin's Disease: A Cytokine-Producing Tumor - A ReviewCritical Reviews™ in Oncogenesis, 1994
- Lymphotoxin, tumour necrosis factor and interleukin‐6 gene transcripts are present in Hodgkin and Reed‐Sternberg cells of most Hodgkin's disease casesBritish Journal of Haematology, 1993
- Prognosis of Hodgkin's disease in not influenced by epstein‐barry virus latent membrane proteinInternational Journal of Cancer, 1992
- Increased levels of circulating interleukin‐6 in patients with hodgkin's diseaseHematological Oncology, 1991
- Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell deathCell, 1991
- Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's diseaseThe Lancet, 1991
- Biological and clinical aspects of interleukin 6Immunology Today, 1990
- Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicity.The Journal of Experimental Medicine, 1990
- Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130Cell, 1989
- Specificity of riboprobes for intracellular RNA in hybridization histochemistry.Journal of Histochemistry & Cytochemistry, 1988